There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline ...
Mizuho analyst Dan Dolev raised the firm’s price target on Block (SQ) to $110 from $94 and keeps an Outperform rating on the shares. The firm says that while several investors have expressed ...
ADC driver amplifiers perform many important functions, including buffering, amplitude scaling, single-ended-to-differential and differential-to-single-ended conversion, common-mode offset adjustment, ...
Have no fear—affinity diagrams are here to save you from getting overwhelmed by the sheer volume of data you’ve gathered. They’ll help you navigate through and organize your data in an incredibly ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account. We offer one free story view per month. If you ...
A key focus of the alliance is to find ways to improve the efficacy of T cell therapies against solid tumours, which has been a stumbling block for developers. So far, T cell therapies such as CAR ...